Although the expression of PARC does not appear to be enhanced in the initial vascular remodeling changes of IC arteries in patients with COPD, its possible role in the pathology of advanced vascular disease cannot be discarded, and has been described previously in the context of atherosclerosis [26]. The gene discussed is CCL18; the disease is chronic obstructive pulmonary disease.